
    
      A target of 75 participants will be randomised 1:1:1 to one of the three treatment arms. Each
      participant will have an implantable loop recorder (ILR) prior to ablation in order to assess
      AF burden. After ablation, each participant will be followed up for a year. The ILR will be
      used to assess reduction in AF burden.
    
  